Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FBTAX vs. RYOIX: which is better?

Bottom line

FBTAX vs RYOIX: the short answer

FBTAX (Fidelity Advisor Biotechnology Fund) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 47% by weight.

FBTAX is cheaper at 0.94% vs 1.38% — a difference of $44 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs +4.0% for RYOIX (reporting dates differ).

Updated Nov 19, 2026

FBTAX vs RYOIX side by side

FBTAXRYOIX
TypeMutual fundMutual fund
Fund familyFidelityGuggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio0.94%1.38%
Annual cost per $10k$94$138
10-yr cost on $10k (prospectus)$1,663$1,709
Max front load——
12b-1 fee0.25%0%
1-yr return+31.5%+30.7%
5-yr return (annualized)+6.4%+4.0%
10-yr return (annualized)+7.7%+5.9%
Best quarter+30.3%+28.3%
Worst quarter−27.8%−22.5%
Net assets (fund)$2.2B$136.8M
Number of holdings12974
Portfolio turnover54%75%
Returns as ofSep 30, 2026Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFBTAXRYOIXDifference
2025+39.6%+30.7%+8.8%
2024+5.3%−0.7%+6.1%
2023+10.7%+6.1%+4.6%
2022−8.0%−13.1%+5.1%
2021−3.6%+1.8%−5.4%
2020+32.2%+22.1%+10.1%
2019+25.7%+25.0%+0.7%
2018−3.8%−9.0%+5.2%
2017+25.8%+29.7%−3.9%
2016−23.6%−19.5%−4.1%

Source: Fund prospectus bar charts

Holdings overlap

11 of FBTAX's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingFBTAXRYOIX
Abbvie Inc14.71%8.17%
Gilead Sciences Inc5.70%4.49%
Alnylam Pharmaceuticals Inc3.62%2.36%
Insmed Inc3.05%1.79%
Revolution Medicines Inc3.00%2.48%
Argenx Se3.00%1.48%
Biogen Inc2.71%2.13%
Amgen Inc2.37%5.05%
Moderna Inc1.60%2.15%
Natera Inc1.43%2.12%
Vertex Pharmaceuticals Inc1.39%4.32%

Source: SEC Form N-PORT

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between FBTAX and RYOIX?
FBTAX (Fidelity Advisor Biotechnology Fund) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 47% by weight. FBTAX is cheaper at 0.94% vs 1.38% — a difference of $44 a year per $10,000 invested.
Which is cheaper, FBTAX or RYOIX?
FBTAX has the lower expense ratio (0.94%).
Should I own both FBTAX and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.